期刊文献+

血管紧张素转换酶抑制剂对肝硬化门静脉高压症患者门静脉血流动力学的影响 被引量:3

Effects of captopril on portal hemodynamics in patients with cirrhotic portal hypertension
全文增补中
导出
摘要 目的观察血管紧张素转换酶抑制剂对肝硬化门静脉高压症门静脉血流动力学的影响,探讨血管紧张素转换酶抑制剂治疗肝硬化门静脉高压症的有效性及机制。方法肝硬化门静脉高压症患者80例,在服用血管紧张素转换酶抑制剂后不同时期,用彩色多普勒超声测量门静脉最大血流速度和门静脉血流量。用放射免疫法测定血浆肾素活性和醛固酮浓度。结果脾切除加断流术的肝硬化患者16例,应用血管紧张素转换酶抑制剂后30分钟、60分钟、1周时,门静脉压力分别下降0.45±0.34 kPa(P<0.05)、0.52±0.32 kPa(P<0.05)、0.43±0.24 kPa(P<0.05),门静脉血流量、最大血流速度较用药前略有增加,但无统计学意义。血浆肾素活性从4±2 mg/ml·h 升高到14±6 mg/ml·h(P<0.05),血浆醛固酮浓度从125±5ng/L 下降到45±4ng/L(P<0.05),未见明显副作用。结论血管紧张素转换酶抑制剂能快速降低门静脉压,不减少门静脉血流量,长期应用降低门静脉压力效果明显。 Objective To evaluate the effects of captopril on portal hemodynamics and explore it's efficiency and mechanism in patients with cirrhotic portal hypertension.Methods 80 patients were enrolled.After taking cap- topril,the maximal portal blood flow velocity,potal diameter,volume of portal blood flow were measured at regular time interval with colour doppler.The plasma renin activity and aldesterone concerntration were deter- mined with radioimmunoassay.The portal vein pressure was measured directly on 16 patients undergoing splenectomy and devascularization.Results At 30 min,60 min,and 1 week after administering captopril,free portal pressure dropped by 0.45±0.34 kPa(P<0.05),0.52±0.32kPa(P<0.05),0.43±0.24kPa(P <0.05)respectively.The volume of portal blood flow and maximal portal flow velocity slightly increased which is not statistically significant.Plasma renin activity rised from 4±2mg/ml·h to 14±6mg/ml·h(P<0.05) and plasma aldosterone concerntration decreased from 125±5ng/L to 45±4ng/L(P<0.05).No severe side- effect was seen.Conclusion Captopril lowers portal vein pressure without reducing volume of portal blood flow .Depressive effect is prompt,constant.
出处 《中华普通外科杂志》 CSCD 1998年第2期99-101,共3页 Chinese Journal of General Surgery
关键词 门静脉高血压 肾素-血管紧张素系统 肽基二肽酶A 血液动力学 Hypertension,portal Renin-angiotensin system Peptidy-dipeptidase A Hemodynamics
  • 相关文献

同被引文献13

  • 1郝丽平,张忠兵,王育敏.肝硬变患者血浆心房钠尿肽、肾素、血管紧张素Ⅱ和醛固酮浓度的变化[J].第四军医大学学报,1994,15(1):74-75. 被引量:7
  • 2卿笃信,陈平,凌奇荷,霍继荣.肝硬化患者血清血管紧张素转换酶测定[J].中国现代医学杂志,1996,6(2):57-58. 被引量:3
  • 3王赋敏 李崇熙 等.马尿酰甘氨酰甘氨酸合成及血清血管紧张素I转换酶测定[J].中华医学检验杂志,1983,6:135-137.
  • 4Ikura Y, Ohsawa M, Shirai N, et al. Expression of angiotensin II type 1 receptor in human cirrhotic livers : Its relation to fibrosis and portal hypertension. Hepatol Res ,2005,32 : 107-116.
  • 5Pinzani M, Failli P, Ruocco C,et al. Fat-storing cells as liver-specific pericytes spatial dynamics of agonist-stimulated intracelullar calcium transients. J Ctin Invest, 1992,90:642.
  • 6Schiveisfurth H, Wernze H. Changes of serum angiotensin I convetting enzyme in patients with viral hepatitis and cirrhosis. Acta Hepato Gastroenterol, 1979,26:207.
  • 7张其胜,中华普通外科杂志,1998年,13卷,99页
  • 8郝丽平,第四军医大学学报,1994年,15卷,74页
  • 9王赋敏,中华医学检验杂志,1983年,6卷,135页
  • 10梁扩寰,李绍白.门静脉高压症.北京:人民军医出版社,1998.332-333.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部